Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online May 29, 2007
Diabetes Care 30:2453-2457, 2007
DOI: 10.2337/dc06-2003
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2003v1
30/10/2453    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herman, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herman, W. H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Clinical Care/Education/Nutrition/Psychosocial Research
Original Article

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

William H. Herman, MD, MPH1, Yong Ma, MS2, Gabriel Uwaifo, MD3, Steven Haffner, MD, MPH4, Steven E. Kahn, MB, CHB5, Edward S. Horton, MD6, John M. Lachin, SCD2, Maria G. Montez, RN, MSHP, CDE7, Tina Brenneman, BS2, Elizabeth Barrett-Connor, MD8 for the Diabetes Prevention Program Research Group*

1 Department of Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan
2 Biostatistics Center, George Washington University, Rockville, Maryland
3 Medstar Research Institute, Washington, DC
4 Department of Medicine, Clinical Epidemiology, University of Texas Health Science Center, San Antonio, Texas
5 Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington
6 Section on Clinical Research, Joslin Diabetes Center, Boston, Massachusetts
7 Diabetes Prevention Program, University of Texas Health Science Center, San Antonio, Texas
8 Department of Family and Preventative Medicine, University of California at San Diego, La Jolla, California

Address correspondence and reprint requests to William H. Herman, MD, Diabetes Prevention Program Coordinating Center, Biostatistics Center, George Washington University, 6110 Executive Blvd., Suite 750, Rockville, MD 20852. E-mail: dppmail{at}biostat.bsc.gwu.edu

OBJECTIVE—We sought to examine racial and ethnic differences in A1C in individuals with impaired glucose tolerance (IGT).

RESEARCH DESIGN AND METHODS— We studied 3,819 individuals aged ≥25 years with IGT who were found to be eligible to participant in the Diabetes Prevention Program. A1C was compared among five racial and ethnic groups before and after adjustment for factors that differed among groups or might affect glycemia including age, sex, education, marital status, blood pressure, adiposity (BMI and waist circumference), hematocrit, fasting and post–glucose load glucose levels, glucose area under the curve (AUC), ß-cell function, and insulin resistance.

RESULTS—Mean ± SD A1C was 5.91 ± 0.50%. Among whites, A1C was 5.80 ± 0.44%, among Hispanics 5.89 ± 0.46%, among Asian 5.96 ± 0.45%, among American Indians 5.96 ± 0.46%, and among blacks 6.19 ± 0.59%. Age, sex, systolic blood pressure, diastolic blood pressure, BMI, fasting glucose, glucose AUC, corrected insulin response, and insulin resistance were each independent predictors of A1C. Adjusting for these and other factors, mean A1C levels were 5.78% for whites, 5.93% for Hispanics, 6.00% for Asians, 6.12% for American Indians, and 6.18% for blacks (P < 0.001).

CONCLUSIONS— A1C levels are higher among U.S. racial and ethnic minority groups with IGT after adjustment for factors likely to affect glycemia. Among patients with IGT, A1C may not be valid for assessing and comparing glycemic control across racial and ethnic groups or as an indicator of health care disparities.

Abbreviations: AUC, area under the curve • CIR, corrected insulin response • DPP, Diabetes Prevention Program • FPG, fasting plasma glucose • HOMA-IR, homeostasis model assessment of insulin resistance • IGT, impaired glucose tolerance • OGTT, oral glucose tolerance test


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
K. E. Bainbridge, C. C. Cowie, K. F. Rust, and J. E. Fradkin
Mitigating Case Mix Factors by Choice of Glycemic Control Performance Measure Threshold
Diabetes Care, September 1, 2008; 31(9): 1754 - 1760.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kahn and V. Fonseca
Translating the A1C Assay
Diabetes Care, August 1, 2008; 31(8): 1704 - 1707.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. K. Kirk, L. V. Passmore, R. A. Bell, K.M. V. Narayan, R. B. D'Agostino Jr., T. A. Arcury, and S. A. Quandt
Disparities in A1C Levels Between Hispanic and Non-Hispanic White Adults With Diabetes: A meta-analysis
Diabetes Care, February 1, 2008; 31(2): 240 - 246.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
N. Iqbal and A. H. Rubenstein
Does Lowering of Blood Glucose Improve Cardiovascular Morbidity and Mortality?
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 163 - 167.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
R. M. Cohen
A1C: Does One Size Fit All?
Diabetes Care, October 1, 2007; 30(10): 2756 - 2758.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.